DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
>>5 Big Charts to Trade for Gains
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
10 Best High Dividend Stocks To Watch For 2015: Receptos Inc (RCPT)
Receptos, Inc. (Receptos), incorporated on June 9, 2008, is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company�� product candidates span three specialty disease areas. The Company�� lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD). Its second asset, RPC4046, is being developed for the treatment of an allergic/immune-mediated disorder, eosinophilic esophagitis (EoE), which is an orphan disease. RPC1063 is an oral, once daily, selective and potent sphingosine 1-phosphate 1 receptor (S1P1R) modulator. RPC4046 is a monoclonal antibody selective to interleukin-13 (IL-13) and produced by recombinant deoxyribonucleic acid (DNA) technology.
As of December 31, 2012, RPC1063 was being tested in the Phase II portion of an accelerated design, randomized Phase II/III study for the treatment of RMS. In addition, Receptos has obtained special protocol assessment (SPA) agreement from the United States food and drug administration (FDA) on its clinical trial design for the planned Phase III portion of the Phase II/III study, as well as a second planned RMS Phase III study. RPC1063 is also being tested in a randomized Phase II study for the treatment of ulcerative colitis (UC), a gastrointestinal (GI) disea se.
As of December 31, 2012, the Company was enrolling a randomized Phase II study evaluating the ability of RPC1063 to induce clinical remission in patients with moderately-to-severely active UC called TOUCHSTONE. The Company�� second asset, RPC4046 for the treatment of EoE, builds upon its competencies in immunology and GI diseases. In-licensed from AbbVie Bahamas Ltd. and AbbVie Inc. (AbbVie) RPC4046 is a monoclonal antibody directed against the IL-13 target, which has been validated in Asthma, a predominantly allergic/immune-mediated disorder.
Advisors' Opinion:- [By Roberto Pedone]
Receptos (RCPT) is a biopharmaceutical company engaged in discovering, developing and commercializing therapeutics for immune disorders. This stock closed up 5% at $23.19 in Monday's trading session.
Monday's Volume: 69,000
Three-Month Average Volume: 55,356
Volume % Change: 50%From a technical perspective, RCPT ripped higher here right above some key near-term support at $21 with decent upside volume. This move is quickly pushing shares of RCPT within range of triggering a major breakout trade. That trade will hit if RCPT manages to take out its all-time high at $25 with high volume.
Traders should now look for long-biased trades in RCPT as long as it's trending above support at $21 and then once it sustains a move or close above its all-time high at $25 with volume that's near or above 55,356 shares. If that breakout hits soon, then RCPT will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $30 to $35.
- [By RichardCox]
For those willing to take on some added volatility (and potential for increased risk based on less diversification), investors can look at Receptos Inc. (RCPT), to play this year's momentum in IPO entries. Enhanced expectations for the company's IPO drove the company to raise its initial share offering to 5.2 million shares. Receptos has reached late-stage development for its oral treatment for multiple sclerosis (MS). MS treatments are dominated by industry heavyweights but MS pills are expected to surge in the next few years because oral treatments are becoming more efficient than injected therapies, and can cater to a broader consumer base. Being a new company, the Receptos chart only offers limited incite, and will not be included here.
Hot Tech Stocks For 2014: MicroStrategy Incorporated(MSTR)
MicroStrategy Incorporated provides enterprise software platforms for business intelligence (BI), and mobile and social intelligence applications worldwide. The company offers MicroStrategy 9, an integrated BI platform that enables businesses to make business decisions. The MicroStrategy 9 platform?s product components comprise Intelligence Server, a foundation for the BI platform; Report Services, a reporting engine delivering production and operational reports, managed metrics reports, and interactive dashboards; OLAP Services that allows Web and desktop users to manipulate Intelligent Cubes databases; Web, a Web interface providing query, reporting, and analysis; Distribution Services that offers automated report and dashboard distribution; Office, which enables Microsoft Office users to create, run, edit, and format MicroStrategy report; and Desktop that provide users access to data through analytical applications. The MicroStrategy 9 platform?s product components al so include Architect, whose data sources are modeled through an intuitive graphical user interface; SDK to integrate MicroStrategy 9 features and functionality into any application on multiple platforms; Integrity Manager to compare and verify reports? consistency; Command Manager that automates MicroStrategy administrative tasks; Enterprise Manager to provide prebuilt reports and dashboards; Object Manager that allows administrators to manage disparate and distributed environments; MultiSource Option allowing users to report, analyze, and monitor data; Transaction Services that provides write-back capabilities; and Clustering Option, a plug-and-play add-on to Intelligence Server. The company also offers technical support, consulting, education, and cloud-based solutions. It serves retail, communications, financial services, insurance, healthcare, manufacturing, technology, consumer goods, and public services industries. The company was founded in 1989 and is headquartered in Tysons Corner, Virginia.
Advisors' Opinion:- [By Victor Selva]
The second place was occupied by MicroStrategy Incorporated (MSTR), a provider of business intelligence and mobile software with 5.5% of the total portfolio and worth $52.6 million. It reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago, and the stock price outperformed the rise in the S&P 500.
Hot Tech Stocks For 2014: Accelrys Inc.(ACCL)
Accelrys, Inc. develops and commercializes scientific business intelligence software and solutions in the United States, Europe, and the Asia Pacific. The company offers Pipeline Pilot, Accelrys enterprise R&D platform, which allows users to aggregate, integrate, and mine structured and unstructured scientific data, such as chemical structures, biological sequences, and complex digital images; and filters, normalizes, and performs statistical analysis on the scientific data and provides visual reports to scientists and scientific managers. It also provides computer aided design modeling and simulation software that allows scientists to perform computations of chemical, biological, and materials properties to simulate, visualize, and analyze chemical and biological systems, as well as communicate the results to other scientists; and data management and informatics software to capture, store, manage, and mine scientific data information. In addition, the company offers Enter prise Lab Notebook, which provides a digital environment to plan, execute, record, store, back-up, and share daily research activities; lab execution systems; and content databases to support research activities through a collection of factual databases and reference works. Further, it provides software wrappers that allows customers to run their own algorithms on the company?s R&D platform; enterprise-wide informatics systems, which integrate customers? internal systems with software from various vendors; contract research services; onsite training and implementation, Web-based training, and data migration services; and support services. The company serves pharmaceutical, biotechnology, agricultural, energy, chemicals, aerospace, consumer packaged goods, and industrial product industries, as well as government and academic entities through direct sales force, telesales, and distributors. Accelrys, Inc. was founded in 1993 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Accelrys (Nasdaq: ACCL ) , whose recent revenue and earnings are plotted below. - [By Alex Planes]
What: Shares of Accelrys (NASDAQ: ACCL ) are down by over 20% today after the company took a big, ugly swing and a miss on its first-quarter earnings and upcoming guidance.
Hot Tech Stocks For 2014: Jabil Circuit Inc.(JBL)
Jabil Circuit, Inc., together with its subsidiaries, provides electronic manufacturing services and solutions worldwide. The company offers electronics and mechanical design, production, product management, and after-market services to companies in the aerospace, automotive, computing, consumer, defense, industrial, instrumentation, medical, networking, peripherals, solar, storage, and telecommunications industries. Its services comprise integrated design and engineering; component selection, sourcing, and procurement; automated assembly; design and implementation of product testing; parallel global production; enclosure services; and systems assembly, direct-order fulfillment, and configure-to-order services. The company also provides set-top boxes, mobility products, and display products, as well as peripheral products, such as printers and point of sale terminals; and aftermarket services consisting of warranty and repair services. Jabil Circuit, Inc. was founded in 196 6 and is headquartered in St. Petersburg, Florida.
Advisors' Opinion:- [By Eric Volkman]
Jabil Circuit (NYSE: JBL ) won't be veering from its dividend policy, at least for now. The company has declared its latest distribution, which is to be $0.08 per share, paid on September 3 to shareholders of record as of August 15. That amount matches each of the firm's seven previous disbursements, the most recent of which was handed out at the beginning of last month. Prior to that, Jabil Circuit paid $0.01 less, at $0.07 per share.
- [By Amber Hestla, Michael J. Carr]
Another Apple supplier to consider is Jabil Circuit (NYSE: JBL), a company that offers a number of manufacturing services to customers in the technology sector.
- [By Paul Ausick]
Apple Inc. (NASDAQ: AAPL) is about to be pilloried again for ��thical and legal��labor violations at the Chinese factory of one of its parts suppliers. A watchdog group called China Labor Watch reports that the Wuxi manufacturing plant of Jabil Circuit Inc. (NYSE: JBL) has failed to pay workers millions of dollars in overtime wages, demanded 100 hours of mandatory overtime pay per month, required more than 11 hours a day of standing work with no rests except a 30-minute meal break, and other violations.
- [By Dan Caplinger]
On Wednesday, Jabil Circuit (NYSE: JBL ) will release its latest quarterly results. Even though the tech manufacturer has tried to emerge from the shadows by diversifying beyond its largest customer, Jabil still faces plenty of competition from other companies seeking to stand behind some of the most popular products in technology.
Hot Tech Stocks For 2014: Omnicell Inc.(OMCL)
Omnicell Inc. provides automated solutions for hospital medication and supply management primarily in the United States and Canada. The company offers medication use products, which include OmniRx that automates the management and dispensing of medications at the point of use; SinglePointe, a software product that controls medications on a patient-specific basis; AnywhereRN, a software that allows nurses to remotely operate automated dispensing cabinets; Pandora Analytics, a reporting and data analytics tool; and Savvy Mobile Medication System, a mobile platform for hospital information systems. Its medication use products also include OmniLinkRx, a software product that automates communication between nurses and the pharmacy; WorkflowRx, an automated storage, retrieval, inventory management, and repackaging solution; controlled substance barcode inventory management system; and Anesthesia Workstation, a secure dispensing system for the management of anesthesia supplies an d medications. In addition, the company provides medical and surgical supply products, which comprise Omnicell Supply Solution that automates the management and dispensing of medical and surgical supplies at the point of use; Supply/Rx Combination Solution, which manages medications and supplies in one versatile cabinet; Omnicell Tissue Center that manages the chain of custody for bone and tissue specimens; OptiFlex SS, which supplies modules for the perioperative areas; OptiFlex CL that supplies modules for the cardiac catheterization lab and other procedure areas; and OptiFlex MS, a system for the management of medical and surgical supplies. Further, it provides customer education and training, and maintenance and support services. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Leo Fasciocco]
Omnicell (OMCL) is organized into two operating business segments: Acute Care, which primarily includes sold to hospitals, and non-acute care, for customers outside of hospitals.
- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Omnicell (Nasdaq: OMCL ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Omnicell doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 33.5%, and inventory increased 53.7%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue expanded 35.8%, and inventory increased 53.7%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 3.4%, and inventory dropped 2.9%. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Omnicell (Nasdaq: OMCL ) , whose recent revenue and earnings are plotted below.
Hot Tech Stocks For 2014: EMC Corporation(EMC)
EMC Corporation develops, delivers, and supports the information and virtual infrastructure technologies and solutions. The company offers enterprise storage systems and software, which are deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, as well as provides backup and recovery, and disaster recovery and archiving solutions. It also offers information security solutions in various areas, such as enterprise governance, risk and compliance, data loss prevention, security information management, continuous network monitoring, fraud protection, identity assurance and access control, and encryption and key management. In addition, the company provides information intelligence software, solutions, and services, including EMC Captiva for intelligent enterprise capture; EMC Document Sciences for customer communications management; EMC Kazeon for e-discovery ; EMC Documentum xCP for building business solutions and an action engine for big data; and the EMC Documentum platform for managing and delivering enterprise information. Further, it offers virtual and cloud infrastructure products, such as virtualization and virtualization-based cloud infrastructure solutions that address a range of IT problems, as well as facilitate access to cloud computing capacity, business continuity, software lifecycle management, and corporate end-user computing device management In addition, the company provides consulting, technology deployment, managed, customer support, and training and certification services. EMC Corporation markets its products through direct sales and through multiple distribution channels in North America, Latin America, Europe, the Middle East, South Africa, and the Asia Pacific region. The company was founded in 1979 and is headquartered in Hopkinton, Massachusetts.
Advisors' Opinion:- [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]
EMC Corp.(EMC) said its second-quarter earnings fell 16% as an increase in revenue was offset by rising costs. The company raised its adjusted earnings view for 2014 by one cent a share. Shares edged up slightly to $28.56 premarket.
No comments:
Post a Comment